Corcept Therapeutics Aktie
72,00
EUR
-16,28
EUR
-18,44
%
79,39
USD
-4,53
USD
-5,40
%
Werbung
Corcept Therapeutics Aktie Analyse
10.08.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
31.05.18 | Corcept Therapeutics Hold | Stifel, Nicolaus & Co., Inc. | |
09.03.18 | Corcept Therapeutics Buy | B. Riley FBR, Inc. | |
31.08.17 | Corcept Therapeutics Buy | Stifel, Nicolaus & Co., Inc. | |
21.04.15 | Corcept Therapeutics Outperform | FBR Capital | |
02.11.09 | Corcept Therapeutics kaufen | Global Biotech Investing | |
15.08.05 | Corcept Therapeutics Buy | Punk, Ziegel & Co | |
25.04.05 | Corcept Therapeutics Outperform | Harris Nesbitt | |
Werbung
|
Werbung
Werbung